Dasiglucagon: all 22 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- A Study to Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children <6 Years With T1DCompletedNCT05378672Phase 3Results posted
- Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital HyperinsulinismCompletedNCT04172441Phase 2/3Results posted
- The Bihormonal iLet Bionic Pancreas Feasibility StudyCompletedNCT03840278Phase 2/3Results posted
- A Two-Period Open-label Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital HyperinsulinismCompletedNCT03777176Phase 3Results posted
- Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DMCompletedNCT03688711Phase 3Results posted
- Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM ChildrenCompletedNCT03667053Phase 3Results posted
- A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes SubjectsCompletedNCT03378635Phase 3Results posted
- A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes MellitusCompletedNCT03216226Phase 3Results posted
- A Stable Glucagon Analog Administered by a Bihormonal Closed Loop SystemWithdrawnNCT05454709Phase 2
- Treatment of Post-bariatric HypoglycaemiaCompletedNCT04836273Phase 2
- Efficacy and Safety of Dasiglucagon for Treatment of Post-bariatric Hypoglycemia in Roux-en-Y Gastric Bypass (RYGB) Operated AdultsWithdrawnNCT04824872Phase 2
- Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 DiabetesCompletedNCT04764968Phase 2
- Low-dose Dasiglucagon for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 DiabetesCompletedNCT04449692Phase 2
- Micro Glucagon During Exercise in Type 1 DiabetesWithdrawnNCT04192019Early Phase 1
- Dasiglucagon in the Treatment of Postprandial Hypoglycaemia After Roux-en-Y Gastric BypassCompletedNCT03984370Phase 2
- Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital HyperinsulinismCompletedNCT03941236Phase 3
- A Trial to Compare the Efficacy and Safety of 2 Different Batches of Subcutaneous Dasiglucagon in Patients With T1DMCompletedNCT03895697Phase 3
- Evaluation of the Safety, Tolerability and Bioavailability of Dasiglucagon Following Subcutaneous (SC) Compared to IV AdministrationCompletedNCT03735225Phase 1
- ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed GlucagonCompletedNCT02916251Phase 2
- Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Marketed GlucagonCompletedNCT02660008Phase 2
- Multiple Ascending Doses of ZP4207 Administered to HV to Evaluate the Safety, Tolerability, PKs and PDs of ZP4207CompletedNCT02390141Phase 1
- Single Ascending Doses of ZP4207 Administered in HV and in T1D to Evaluate Safety, Tolerability PKs and PDs of ZP4207 Compared to a ComparatorCompletedNCT02367053Phase 1